Immunoediting is a dynamic process that consists of immunosurveillance and tumor progression. It describes the relation between the tumor cells and the immune system. It is made up of three phases: elimination, equilibrium, and escape.[1]
^Dunn, Gavin P.; Old, Lloyd J.; Schreiber, Robert D. (2004). "The Three Es of Cancer Immunoediting". Annual Review of Immunology. 22 (1): 329–360. CiteSeerX 10.1.1.459.1918. doi:10.1146/annurev.immunol.22.012703.104803. PMID 15032581.
referred to as "the three Es" of cancer immunoediting. Both adaptive and innate immune system participate in immunoediting. In the elimination phase, the immune...
roles of IFN gamma in protection against tumor development and cancer immunoediting". Cytokine & Growth Factor Reviews. 13 (2): 95–109. doi:10.1016/s1359-6101(01)00038-7...
S2CID 205016599. Dunn GP, Old LJ, Schreiber RD (2004). "The three Es of cancer immunoediting". Annual Review of Immunology. 22 (i): 329–360. doi:10.1146/annurev...
by increasing the number attacking a single antigen. During "cancer immunoediting", tumor cells can produce antigens that provoke a reduced immune response...
roles of IFN gamma in protection against tumor development and cancer immunoediting". Cytokine & Growth Factor Reviews. 13 (2): 95–109. doi:10.1016/S1359-6101(01)00038-7...
Christine G. (2022-04-11). "The spatial landscape of progression and immunoediting in primary melanoma at single cell resolution". Cancer Discovery. 12...
that a TH1 cell/cytotoxic immune activation, as captured by the ICR, immunoediting, concurrent expansion of TCR clonotypes and specific intratumoral microbiome...
in breast cancer: Controversies on contributions to tumour, host and immunoediting processes". Pharmacological Research. 119: 278–288. doi:10.1016/j.phrs...
roles of IFN gamma in protection against tumor development and cancer immunoediting". Cytokine & Growth Factor Reviews. 13 (2): 95–109. doi:10.1016/s1359-6101(01)00038-7...
PMID 16955181. Baltz KM, Krusch M, Bringmann A, et al. (2007). "Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans:...
the development of the cancer immunosurveillance theory and cancer immunoediting hypothesis. At the end of the 1980s the three-dimensional structure...
PMID 16955181. Baltz KM, Krusch M, Bringmann A, et al. (2007). "Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans:...
Global Information